Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a ...

A key US approval is great news for this company. The post Which biotech company's shares have rocketed to a new high on good ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company’s severe epilepsy ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

This clinical-stage biotech specializing in antibody therapeutics reported a notable insider sale amid ongoing development and partnerships.

BioPharma Consulting Group today announced the launch of a new digital transformation advisory framework designed to ...

Albuquerque-based EquiSeq is a biotech company developing DNA tests for inherited muscle diseases, like muscle integrity ...

This biotech innovator in antibody therapies for inflammatory bowel disease reported a notable insider sale, according to a recent SEC filing.

From lab space and coffee bars to jobs and long-term returns, mid-tier life sciences hubs may be better positioned than the biggest biotech boomtowns.

The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...